Centrale Del Latte Di Italia: Recovery Continues

 | Nov 15, 2017 08:05AM ET

Centrale del Latte Di Italia SpA (MI:CLII) price increases – which were successfully implemented during H1 – continue to drive the recovery. Underlying sales growth excluding M&A was an impressive 14% during Q317, and EBITDA margin more than doubled from 2.0% in Q316 to 5.4% in Q317. Revenue synergies continue to feature following the acquisition of CLF, as cross-selling of products across the CLI platform continues to contribute to growth. In October CLI announced that it had signed an agreement with Alibaba (NYSE:BABA) to sell its UHT milk online to Chinese consumers. While we have cut our near-term estimates to reflect recent increases in raw material costs, we raise our medium-term revenue growth by 100bp to capture the potential growth opportunity in China. Our fair value rises to €3.25/share (from €2.94 previously).